Nektar Therapeutics (NKTR) support and resistance · rev $21.0M
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
This page maps Nektar Therapeutics (NKTR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported NKTR revenue for 2026-06-30 was $21.0M. Net income was -$85.5M. Revenue was up 93.3% from 2026-03-31 to 2026-06-30. NKTR currently screens at market cap $307.2M.
NKTR currently screens at market cap $307.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new NKTR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the NKTR quote page for the session range and the stock page for the full model.
Not investment advice.